Aegis Health Group welcomes Hal Andrews, Jeff Pate, and Will Fitzgibbon to its Board of Directors

– USA, TN – Aegis Health Group, a leading provider of patient acquisition and retention solutions for health systems, is pleased to announce that Hal Andrews, Jeff Pate, and Will Fitzgibbon have joined its Board of Directors. Additionally, Henry Ross has rejoined the board after a two year hiatus.

“We are pleased to welcome these gentlemen to Aegis’ Board of Directors,” said Lori Copeland, CFO and Interim CEO of Aegis. “They bring a wealth of expertise and will be tremendous assets to Aegis as we further our mission of positioning our clients as the trusted healthcare resource in their communities.”

“I am honored to serve as Aegis’ board chairman,” said Hal Andrews. “I believe that Aegis’ focus on providing health systems a unique business development solution to engage employers and physicians is needed more than ever in an uncertain and challenging reimbursement environment. Aegis has a proven track record of delivering value to health systems, and I look forward to working closely with their team to position the company for future growth.

Mr. Andrews has over 20 years’ experience as a successful entrepreneur, investor and healthcare business leader. Over the past decade, he has served in executive roles at Digital Reasoning, Shareable Corporation, Availity, LLC, RevPoint Healthcare Technologies, Martin Ventures and Data Advantage. Mr. Andrews began his career as an attorney with Waller Lansden Dortch and Davis.

Mr. Pate is the Chief Development Officer at Pershing Yoakley & Associates with an extensive background in growing and managing healthcare businesses. Jeff began his career with a national CPA and advisory firm, and has since served as an executive with numerous healthcare technology and service companies. Most recently, he served as Executive Vice President at Aegis Health Group.

Mr. Fitzgibbon, founder of Silvermark Partners, has over 25 years’ experience as an investment banker representing growth companies in a wide variety of merger and acquisition transactions and public and private equity and debt transactions with a particular emphasis in healthcare. He began his career with J.C. Bradford & Co., and subsequently served as a managing director in healthcare investment banking at Jeffries.

Mr. Ross is an investor, advisor and consultant to companies primarily in the healthcare industry. He joined Aegis in 2000 as the company’s COO, was its CEO from 2007 to 2011 and previously served on Aegis’ board of directors from 2004 to 2014. His career in healthcare spans nearly four decades. Immediately prior to joining Aegis, he served in a variety of senior management roles with PhyCor, a publicly held physician practice management company.

“Aegis is grateful for the many years of service of our outgoing members Michael Barton, Clyde Bright and Rollie Wussow,” concluded Copeland.

About Aegis Health Group

For 28 years, Aegis Health Group, has assisted hundreds of hospitals and health systems grow revenue through its award-winning patient acquisition and retention solutions. Our technology-driven approach enables hospitals to acquire new patients and increase market share by identifying the health risks of the local consumer and connecting them to the health system. Once consumers are engaged with the health system, our strategy aligns hospitals and their medical staff in a way that drives service-line growth, increases referrals, and retains patients within the system.

For more information about Aegis Health Group, a privately-held company based in Brentwood, Tennessee:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here the original post =>